Susquehanna Fundamental Investments, LLC Kala Pharmaceuticals, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.25 - $11.7 $15,341 - $717,982	-61,366 Reduced 78.57%	16,733 $4,000
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $12,218 - $36,857	-20,031 Reduced 20.41%	78,099 $108,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $26,155 - $61,781	-22,548 Reduced 18.68%	98,130 $119,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $5.43 $241,721 - $500,971	92,260 Added 324.65%	120,678 $316,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $8.15 $143,795 - $231,606	28,418 New	28,418 $151,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $123,750 - $183,315	-16,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $137,445 - $227,535	16,500 New	16,500 $173,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $7.83M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.